http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2632345-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-10001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
filingDate 2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_368bdd0a64216a2002b6630d7018feef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d290fa4643d2a2cdcd36e4071b1efc27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a15a323f274e48559de4e197bd81b47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fcef86930615829b37a453cf2dafa25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50676f21a54759828e788aacb5a99d42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8a6437fcb8c97a28e7f0e2f58c86907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87f5783993633341964259ed1c4e6ad8
publicationDate 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2632345-T3
titleOfInvention Inhibition of AXL signaling in antimetastatic therapy
abstract A soluble AXL variant polypeptide, wherein said polypeptide lacks the AXL transmembrane domain and has a set of amino acid modifications of the wild-type AXL sequence (SEQ ID NO: 1), selected from the group consisting of: 1) Gly32Ser , Asp87Gly, Val92Ala and Gly127Arg, 2) Glu26Gly, Val79Met, Val92Ala and Gly127Glu; and 3) Gly32Ser, Ala72Val, Asp87Gly, Val92Ala and Gly127Arg; wherein said modification increases the binding affinity of the AXL polypeptide to the growth-specific protein 6 (GAS6); and where the position of each amino acid modification is represented as n, and n + 7 is equivalent to the numbering of SEQ ID NO: 1.
priorityDate 2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00587
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22893
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27406
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27405
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5PY51
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27404
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36285
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP89681
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02879
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36284
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCW6JHZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8242
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO72120
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9G059
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID126306
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19192
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70695
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3040
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13840
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5728
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID653808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419568501
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DOK3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9INJ1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD1MEI6

Total number of triples: 66.